InsidersTradesSigma
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Browse the full record of transactions filed by Koch Kevin. Director active across 1 company, notably Edgewise Therapeutics, Inc.. Cumulatively, 11 filings have been published. Split: 0 buy · 3 sells. Total volume traded: €680k. Activity tracked since 1 May 2023. The latest transaction was filed on 12 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 de 11 declaraciones
KOCH KEVIN is a declarant linked to Edgewise Therapeutics, Inc., where he is President and CEO. The record shows 5 filings in total, and the sampled recent filings run from 2023-05-03 to 2025-05-07, with the modal transaction nature listed as option exercise.